Triple
T826608
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | UK Home Office |
E17866
|
entity |
| Predicate | oversees |
P46
|
FINISHED |
| Object |
Advisory Council on the Misuse of Drugs
The Advisory Council on the Misuse of Drugs is an independent expert body in the United Kingdom that advises the government on drug-related issues, including classification, harms, and policy.
|
E96679
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Advisory Council on the Misuse of Drugs | Statement: [UK Home Office, oversees, Advisory Council on the Misuse of Drugs]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Advisory Council on the Misuse of Drugs Context triple: [UK Home Office, oversees, Advisory Council on the Misuse of Drugs]
-
A.
Inter-American Drug Abuse Control Commission
The Inter-American Drug Abuse Control Commission is a specialized body of the Organization of American States that coordinates regional policies and programs to prevent and combat drug abuse and illicit trafficking in the Americas.
-
B.
National Institute on Drug Abuse
The National Institute on Drug Abuse is a U.S. federal research agency that leads scientific study on drug use, addiction, and their health impacts to inform prevention, treatment, and policy.
-
C.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
D.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
E.
Drug and Alcohol Clearinghouse
The Drug and Alcohol Clearinghouse is a U.S. national database that tracks commercial drivers’ drug and alcohol program violations to enhance roadway safety and ensure compliance with federal regulations.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Advisory Council on the Misuse of Drugs Triple: [UK Home Office, oversees, Advisory Council on the Misuse of Drugs]
Generated description
The Advisory Council on the Misuse of Drugs is an independent expert body in the United Kingdom that advises the government on drug-related issues, including classification, harms, and policy.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Advisory Council on the Misuse of Drugs Target entity description: The Advisory Council on the Misuse of Drugs is an independent expert body in the United Kingdom that advises the government on drug-related issues, including classification, harms, and policy.
-
A.
Inter-American Drug Abuse Control Commission
The Inter-American Drug Abuse Control Commission is a specialized body of the Organization of American States that coordinates regional policies and programs to prevent and combat drug abuse and illicit trafficking in the Americas.
-
B.
National Institute on Drug Abuse
The National Institute on Drug Abuse is a U.S. federal research agency that leads scientific study on drug use, addiction, and their health impacts to inform prevention, treatment, and policy.
-
C.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
D.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
E.
Drug and Alcohol Clearinghouse
The Drug and Alcohol Clearinghouse is a U.S. national database that tracks commercial drivers’ drug and alcohol program violations to enhance roadway safety and ensure compliance with federal regulations.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a4937c9c188190aaa216f6b466f452 |
completed | March 1, 2026, 7:29 p.m. |
| NER | Named-entity recognition | batch_69a4ab989748819091a3809a747a1c5b |
completed | March 1, 2026, 9:11 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a76d9577f081908aa31b1926e04bb8 |
completed | March 3, 2026, 11:24 p.m. |
| NEDg | Description generation | batch_69a78204c1208190b2d2d19cdea93b57 |
completed | March 4, 2026, 12:51 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69a78648601881908bfcb9390ac4d6d2 |
completed | March 4, 2026, 1:09 a.m. |
Created at: March 1, 2026, 7:38 p.m.